Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%

RTTNews | hace 790
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%

(RTTNews) - Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.

The products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin, NovoLog and NovoLog Mix 70/30.

Novo Nordisk is also reducing the list price of unbranded biologics to match the lowered price of each respective branded insulin. These changes will go into effect on January 1, 2024.

Novo Nordisk currently provides co-pay support for a number of insulin products, meaning eligible patients can pay $25 to $35 for their insulin.

Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the Company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability.

Novo Nordisk continually reviews and revises its offerings as well as works with diverse stakeholders to create solutions for differing patient needs.

read more
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews | hace 5
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply

Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply

Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews | hace 321
Dollar Extends Gains As Trade Tensions Ease

Dollar Extends Gains As Trade Tensions Ease

It was another positive week for the greenback as easing trade tensions and hopes of a deal with China helped the U.S. Dollar build on gains made in the previous week.
RTTNews | hace 48 minutos
Fox Q3 Profit Down, Revenues Climb, Both Ahead Of Market; Stock Gains

Fox Q3 Profit Down, Revenues Climb, Both Ahead Of Market; Stock Gains

Media firm Fox Corp. reported Monday weak earnings in its third quarter on higher expenses, while revenues were higher, benefited mainly by advertising revenue growth of 65 percent, primarily due to the impact of Super Bowl LIX. Adjusted earnings and top line beat market estimates. In pre-market activity on the Nasdaq, the FOX shares were gaining around 3.8 percent.
RTTNews | hace 2h 29min
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

The Canadian market is likely to open with a strong positive gap on Monday, tracking gains in global markets amid easing tariff concerns following China and the U.S. striking a deal over the weekend.
RTTNews | hace 2h 52min
U.S., China Reach Agreement To Slash Tariffs

U.S., China Reach Agreement To Slash Tariffs

Following closely watched meetings over the weekend in Geneva, Switzerland, the U.S. and China have announced an agreement to drastically reduce tariffs on each other's goods. The White House said the agreement calls for the U.S. and China to each lower tariffs by 115 percent while retaining an additional 10 percent tariff.
RTTNews | hace 3h 29min